Considerations in the Cataract Patient with Glaucoma. Robert Noecker, MD, MBA Ophthalmic Consultants of Connecticut Fairfield, CT

Size: px
Start display at page:

Download "Considerations in the Cataract Patient with Glaucoma. Robert Noecker, MD, MBA Ophthalmic Consultants of Connecticut Fairfield, CT"

Transcription

1 Considerations in the Cataract Patient with Glaucoma Robert Noecker, MD, MBA Ophthalmic Consultants of Connecticut Fairfield, CT

2 Financial Disclosure Dr. Noecker has been a paid consultant to Allergan, Alcon, EndoOptiks, Aton, and Ocular Therapeutics within the past year Speakers bureau: Allergan, Alcon, EndoOptiks, Merck, Lumenis Research Support: Glaukos, SOLX, Ocular Therapeutics, Lumenis 9/10/2013 NOECKER- 2011

3 When to do Cataract Surgery Alone? Milder glaucoma Few pre-op medications Can tolerate IOP spike Pure Narrow Angle component Not expecting needing dramatic IOP reduction Worry about complications of glaucoma surgery 9/10/2013 NOECKER- 2011

4 Which eyes do we have to be particularly careful of in terms of their glaucoma? Split fixation Central loss on both sides of horizontal midline Steroid Responders Poor IOP control pre-op 9/10/2013 NOECKER- 2011

5 What precautions do you take if you do CE alone? Thorough viscoelastic removal Glaucoma eye drops Alpha agonists, beta blockers, CAIs PGAs? Systemic CAIs Same day IOP checks 9/10/2013 NOECKER- 2011

6 When to do Combined? Replacement medical therapy Prevention of IOP spikes Eyes with previous failed procedures Chronic angle closure Cataract Surgery not expected to be adequate 9/10/2013 NOECKER- 2011

7 More Traditional Choices for Combined Glaucoma Trabeculectomy Ex-PRESS Surgery Glaucoma Draingage Devices (Ahmed, Baerveldt, Molteno) Canaloplasty Trabectome 9/10/2013 NOECKER- 2011

8 Less Invasive Options istent (Glaukos) Endscopic Cyclophotocoagulation (ECP) 9/10/2013 NOECKER- 2011

9 Why choose combined Phaco-istent or Phaco- ECP? Don t need IOP of 10 mm Hg Replacement medical therapy Eyes at risk for hypotony i.e. Vitrectomized Eyes Anticoagulant concerns Poor conjuncitva/sclera Refractive Error concerns 9/10/2013 NOECKER- 2011

10 9/10/2013 NOECKER Phaco Istent

11 % eyes Efficacy at One Year from US Pivotal Trial 4 istent + Cataract Surgery vs. Cataract Surgery Only IOP 21 mmhg w/o meds IOP 20% w/o meds p = p < Cat sx only istent + Cat sx Cat sx only istent + Cat sx istent safety and efficacy shown through extensive experience R. Noecker, MD 2011 OSN NY excludes data after 2 nd surgery 4. Samuelson, et al. Ophthalmology 2011: 118:

12 Excellent Safety Profile Through 2 Years *1,2 Event istent + Cataract Surgery (N=116) Cataract Surgery Only (N=117) Any BCVA loss 1 line 3 months 7% 10% Posterior capsular opacification 6% 10% Elevated IOP 4% 7% Elevated IOP - other 3% 4% Elevated IOP req g treatment with 1% 3% oral or IV meds or with surgical intervention Stent obstruction 4% 0% Blurry vision or visual disturbance 3% 7% Stent malposition 3% 0% Iritis 1% 5% Conjunctival irritation due to hypotensive meds 1% 3% Disc hemorrhage 1% 3% R. Noecker, MD 2011 OSN NY * Postoperative Ocular Adverse Events Occurring 3 in Either Group 1. Myers, J, et al AGS 2. Craven ER, et al ASCRS 12

13 Mean # Medications Mean IOP (mmhg) Multiple Trabecular Bypass in Combined Phaco 5 Mean IOP and Mean # Medication Over Time 50% 73% pre W1 M1 M3 M6 M12 5. Ahmed, et al. AGS 2010 R. Noecker, MD 2011 OSN NY 13

14 9/10/2013 NOECKER- 2011

15 Endoscopic istent Placement 9/10/2013 NOECKER- 2011

16 Combined Phaco-ECP 9/10/2013 NOECKER- 2011

17 ECP Lowers IOP Longer than Phaco Alone mmhg 1.53 Meds 1.20 Meds 1.20 Meds 0.65 Meds

18 9/10/2013 NOECKER ECP is titratable

19 ECP can be done through cataract incisions 9/10/2013 Noecker ASCRS 2013

20 9/10/2013 NOECKER ECP Technique

21 Plateau iris -sp angle closure 9/10/2013 NOECKER- 2011

22 ECP Complications are predictable, avoidable, and manageable IOP spike (retained viscoelastic) Transient Hemorrhage Inflammation (CME not at higher rate than cataract alone) Pupil Irregularity (anterior burns) Any complication associated with anterior segment surgery 9/10/2013 NOECKER- 2011

23 ECP is well reimbursed Free Standing Ambulatory Surgery Center (ASC or FOSC) Procedure Surgeon CPT Code Payment ASC Code Facility Payment Cataract only ECP only Cataract with ECP ECP done at time of Cataract

24 Advantage to each Phaco alone Least risk Least expensive Phaco/iStent No alteration in post-op medications or follow-up Least amount of inflammation Faster procedure if successful first try Phaco/ECP More efficacious Better reimbursement/ coverage Able to do in eyes with abnormal angles Able to do in poor cornea situations 9/10/2013 NOECKER- 2011

25 ECP and istent can be easliy combined 9/10/2013 NOECKER- 2011

26 9/10/2013 NOECKER- 2011

MIGS Rapid Fire Outline 1 st talk: Goniotomy, Lisa Young, OD, FAAO

MIGS Rapid Fire Outline 1 st talk: Goniotomy, Lisa Young, OD, FAAO Rapid Fire MIGS A Modern Solution to a Complex Problem Course Description: Minimally (or Micro-) Invasive Glaucoma Surgeries, or MIGS, are an increasingly popular treatment modality in the management of

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Aqueous Shunts and Devices for Glaucoma File Name: Origination: Last CAP Review: Next CAP Review: Last Review: aqueous_shunts_and_devices_for_glaucoma 3/2010 6/2017 6/2018 6/2017

More information

Aqueous Shunts and Stents for Glaucoma. (90321) (Formerly Aqueous Shunts for Glaucoma)

Aqueous Shunts and Stents for Glaucoma. (90321) (Formerly Aqueous Shunts for Glaucoma) Protocol Aqueous Shunts and Stents for Glaucoma (90321) (Formerly Aqueous Shunts for Glaucoma) Medical Benefit Effective Date: 01/01/13 Next Review Date: 01/14 Preauthorization* No Review Dates: 03/10,

More information

Endo Optiks. Clinical Publication Summaries

Endo Optiks. Clinical Publication Summaries Endo Optiks Clinical Publication Summaries Effective. Safe. Simple. Four scientific studies demonstrating the proven clinical benefits of combined ECP and cataract surgery. ECP is an Effective, Safe, and

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Protocol Aqueous Shunts and Stents for Glaucoma (90321) Medical Benefit Effective Date: 04/01/14 Next Review Date: 01/15 Preauthorization No Review Dates: 03/10, 03/11, 07/11, 01/12, 09/12, 01/13, 01/14

More information

Cataract-Glaucoma Preoperative considerations. Dimitrios Mikropoulos

Cataract-Glaucoma Preoperative considerations. Dimitrios Mikropoulos Cataract-Glaucoma Preoperative considerations Dimitrios Mikropoulos Cataract surgery alone Trabeculectomy alone Combined surgery The cataract is visually significant, and the glaucoma is well controlled

More information

Optometrist's Guide to Glaucoma Surgery. Goals. Glaucoma Philosophy. I have no financial disclosures

Optometrist's Guide to Glaucoma Surgery. Goals. Glaucoma Philosophy. I have no financial disclosures Optometrist's Guide to Glaucoma Surgery Anthony DeWilde, OD FAAO I have no financial disclosures 1 2 Goals Glaucoma Philosophy Glaucoma can be a visually debilitating disease. How glaucoma surgery works

More information

WHY MIGS 7/26/18. MIGs in the BIGs A professional level understanding of MIGs. Human Cost of Glaucoma. Standard Treatment Options for Glaucoma

WHY MIGS 7/26/18. MIGs in the BIGs A professional level understanding of MIGs. Human Cost of Glaucoma. Standard Treatment Options for Glaucoma Financial Disclosures for Mitch Ibach OD, FAAO MIGs in the BIGs A professional level understanding of MIGs Glaukos Alcon Equinox LLC. Mitch Ibach OD, FAAO Vance Thompson Vision Human Cost of Glaucoma WHY

More information

Micro-Invasive Glaucoma Surgery (Aqueous Stents)

Micro-Invasive Glaucoma Surgery (Aqueous Stents) Micro-Invasive Glaucoma Surgery (Aqueous Stents) Policy Number: Original Effective Date: MM.06.029 02/01/2019 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 02/01/2019 Section:

More information

Keeping Current in Glaucoma Surgery

Keeping Current in Glaucoma Surgery Keeping Current in Glaucoma Surgery #51596-GL COPE April 2018 Ilya Rozenbaum, MD Matossian Eye Associates Financial Disclosures Alcon Allergan B+L Glaukos Human Cost of Glaucoma Glaucoma is the second

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Aqueous Shunts and Stents for Glaucoma Policy Number: 9.03.21 Last Review: 8/2018 Origination: 9/2008 Next Review: 1/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

Optometric Postoperative Cataract Surgery Management

Optometric Postoperative Cataract Surgery Management Financial Disclosures Optometric Postoperative Cataract Surgery Management David Dinh, OD Oak Cliff Eye Clinic Dallas Eye Consultants March 10, 2015 Comanagement Joint cooperation between two or more specialists

More information

Micro-Invasive Glaucoma Surgery (Aqueous Stents)

Micro-Invasive Glaucoma Surgery (Aqueous Stents) Micro-Invasive Glaucoma Surgery (Aqueous Stents) Policy Number: Original Effective Date: MM.06.029 02/01/2019 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 02/01/2019 Section:

More information

Financial Disclosure. The TVT Mentality. Outline. A Case-based Approach to Caring for the Glaucoma Patient: Malik Y. Kahook, MD

Financial Disclosure. The TVT Mentality. Outline. A Case-based Approach to Caring for the Glaucoma Patient: Malik Y. Kahook, MD A Case-based Approach to Caring for the Glaucoma Patient: Advances in Glaucoma Surgery Malik Y. Kahook, MD The Slater Family Endowed Chair in Ophthalmology Professor of Ophthalmology Vice Chair, Clinical

More information

Glaucoma Surgical Treatments. Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD

Glaucoma Surgical Treatments. Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD Glaucoma Surgical Treatments Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD Disclosures Murray Fingeret Consultant Bausch & Lomb, Alcon, Allergan Justin Schweitzer Allergan, Glaukos, Bausch and

More information

EXP11677SK. Financial Disclosure. None to be Declared EXP11677SK

EXP11677SK. Financial Disclosure. None to be Declared EXP11677SK Financial Disclosure None to be Declared Presentation overview Glaucoma Surgical History Complications of trabeculectomy Express Device Specifications Surgical Steps Clinical advantages, indications and

More information

Aqueous Shunts and Stents for Glaucoma. Description

Aqueous Shunts and Stents for Glaucoma. Description Subject: Aqueous Shunts and Stents for Glaucoma Page: 1 of 13 Last Review Status/Date: June 2015 Aqueous Shunts and Stents for Glaucoma Description Glaucoma is not a single entity; there are many subcategories

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Aqueous Shunts and Stents for Glaucoma Policy Number: 9.03.21 Last Review: 1/2014 Origination: 9/2008 Next Review: 1/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

Cataract Surgery in Eyes with Glaucoma

Cataract Surgery in Eyes with Glaucoma Cataract Surgery in Eyes with Glaucoma Malik Y. Kahook, MD The Slater Family Endowed Chair in Ophthalmology Professor of Ophthalmology Vice Chair, Clinical and Translational Research University of Colorado

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Aqueous Shunts and Stents for Glaucoma Policy Number: 9.03.21 Last Review: 1/2018 Origination: 9/2008 Next Review: 1/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

Understanding Angle Closure

Understanding Angle Closure Case Understanding Angle Closure Dominick L. Opitz, OD, FAAO Associate Professor Illinois College of Optometry 56 year old Caucasian Male Primary Eye Exam BCVA: 20/25 OD with+1.25 DS 20/25 OS with +1.75

More information

New Technologies for Treating Glaucoma in Patients Undergoing Cataract Surgery

New Technologies for Treating Glaucoma in Patients Undergoing Cataract Surgery New Technologies for Treating Glaucoma in Patients Undergoing Cataract Surgery Joseph L Lin 1 and Hylton R Mayer 2 1. Ophthalmology Resident; 2. Assistant Professor, Department of Ophthalmology and Visual

More information

One-year Results of a Schlemm s Canal Microstent for IOP Reduction in Open Angle Glaucoma

One-year Results of a Schlemm s Canal Microstent for IOP Reduction in Open Angle Glaucoma One-year Results of a Schlemm s Canal Microstent for IOP Reduction in Open Angle Glaucoma Thomas W. Samuelson, MD Minnesota Eye Consultants On Behalf of the HYDRUS I Investigators 1 Disclosures This study

More information

GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: GL)

GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: GL) MIGS: How did we get here? GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: 55570-GL) John Gelvin, O.D., F.A.A.O. MOYES EYE CENTER Kansas City, Missouri jgelvin@moyeseye.com 1. Tube vs Trabeculectomy?

More information

Highlights On The Management Of Phacomorphic Glaucoma

Highlights On The Management Of Phacomorphic Glaucoma Highlights On The Management Of Phacomorphic Glaucoma Ahmed Aboueleinein What is phacomorphic glaucoma? It is a secondary angle closure glaucoma due to lens intumescence Advanced cataract or traumatic

More information

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY Clinical criteria used to make utilization review decisions are based on credible scientific evidence published in peer reviewed medical literature generally recognized by the medical community.

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of ab interno supraciliary microstent insertion with phacoemulsification for primary

More information

Aqueous Shunts and Stents for Glaucoma. Populations Interventions Comparators Outcomes Individuals: With refractory open-angle glaucoma.

Aqueous Shunts and Stents for Glaucoma. Populations Interventions Comparators Outcomes Individuals: With refractory open-angle glaucoma. Protocol Aqueous Shunts and Stents for Glaucoma (90321) Medical Benefit Effective Date: 04/01/15 Next Review Date: 11/18 Preauthorization No Review Dates: 03/10, 03/11, 07/11, 01/12, 09/12, 01/13, 01/14,

More information

Chronicity. Narrow Minded. Course Outline. Acute angle closure. Subacute angle closure. Classification of Angle Closure 5/19/2014

Chronicity. Narrow Minded. Course Outline. Acute angle closure. Subacute angle closure. Classification of Angle Closure 5/19/2014 Chronicity Narrow Minded The management of narrow angles in the optometric practice Acute Subacute Chronic Aaron McNulty, OD, FAAO Course Outline Classification of Angle Closure Evaluation of narrow angles

More information

Subject Index. Canaloplasty aqueous outflow system evaluation 110, 111 complications 118, 119 historical perspective 109, 110

Subject Index. Canaloplasty aqueous outflow system evaluation 110, 111 complications 118, 119 historical perspective 109, 110 Subject Index Ab externo Schlemm canal surgery, see Canaloplasty, Viscocanalostomy Ab interno Schlemm canal surgery, see istent, Trabectome Adjustable sutures 14, 15 AGV glaucoma drainage implants 43,

More information

Management of Angle Closure Glaucoma Hospital Authority Convention 18 May 2015

Management of Angle Closure Glaucoma Hospital Authority Convention 18 May 2015 Management of Angle Closure Glaucoma Hospital Authority Convention 18 May 2015 Jimmy Lai Clinical Professor Department of Ophthalmology The University of Hong Kong 1 Primary Angle Closure Glaucoma PACG

More information

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY PAGE: 1 OF: 8 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.

More information

EFFICACY AND SAFETY OF CANALOPLASTY IN SAUDI PATIENTS WITH UNCONTROLLED OPEN ANGLE GLAUCOMA

EFFICACY AND SAFETY OF CANALOPLASTY IN SAUDI PATIENTS WITH UNCONTROLLED OPEN ANGLE GLAUCOMA EFFICACY AND SAFETY OF CANALOPLASTY IN SAUDI PATIENTS WITH UNCONTROLLED OPEN ANGLE GLAUCOMA DR.FAISAL ALMOBARAK ASSISTANT PROFESSOR AND CONSULTANT DEPARTMENT OF OPHTHALMOLOGY COLLEGE OF MEDICINE AND KING

More information

Efficacy and Adverse Event Profile of the istent and istent Inject Trabecular Micro-bypass for Open-angle Glaucoma: A Meta-analysis

Efficacy and Adverse Event Profile of the istent and istent Inject Trabecular Micro-bypass for Open-angle Glaucoma: A Meta-analysis JOCGP Efficacy and Adverse Event Profile of the istent and istent Inject Trabecular Micro-Bypass 10.5005/jp-journals-10028-1248 for Open-Angle Glaucoma ORIGINAL ARTICLE Efficacy and Adverse Event Profile

More information

AC & ACG Instruction Course Surgical Treatments for PACG

AC & ACG Instruction Course Surgical Treatments for PACG AC & ACG Instruction Course Surgical Treatments for PACG Presented by APGS Clement C.Y. THAM Professor, The Chinese University of Hong Kong Chief of Service, Hong Kong Eye Hospital Deputy Secretary-General,

More information

Aqueous Shunts and Stents for Glaucoma Section 9.0 Other Subsection 9.03 Vision

Aqueous Shunts and Stents for Glaucoma Section 9.0 Other Subsection 9.03 Vision 9.03.21 Aqueous Shunts and Stents for Glaucoma Section 9.0 Other Subsection 9.03 Vision Effective Date January 30, 2015 Original Policy Date January 30, 2015 Next Review Date January 2016 Description Glaucoma

More information

Objectives. Tubes, Ties and Videotape: Financial Disclosure. Five Year TVT Results IOP Similar

Objectives. Tubes, Ties and Videotape: Financial Disclosure. Five Year TVT Results IOP Similar Tubes, Ties and Videotape: Surgical Video of Glaucoma Implants and Financial Disclosure I have no financial interests or relationships to disclose. Herbert P. Fechter MD, PE Eye Physicians and Surgeons

More information

New options for combined cataract and glaucoma surgery

New options for combined cataract and glaucoma surgery REVIEW C URRENT OPINION New options for combined cataract and glaucoma surgery Donald L. Budenz a and Steven J. Gedde b Purpose of review To review the current literature regarding the effectiveness and

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Last Review: September 2016 Next Review: September 2017 Related Policies 9.03.06 Opthalmalologic Techniques for Evaluating Glaucoma 9.03.26 Viscocanalostomy and Canaloplasty Aqueous

More information

MEDICAL POLICY POLICY TITLE AQUEOUS SHUNTS AND STENTS FOR GLAUCOMA POLICY NUMBER

MEDICAL POLICY POLICY TITLE AQUEOUS SHUNTS AND STENTS FOR GLAUCOMA POLICY NUMBER Original Issue Date (Created): October 1, 2010 Most Recent Review Date (Revised): January 28, 2014 Effective Date: May 1, 2014 I. POLICY Insertion of aqueous shunts approved by the U.S. Food and Drug Administration

More information

9/25/2018. New Generation Glaucoma Care. Disclosures. Overview

9/25/2018. New Generation Glaucoma Care. Disclosures. Overview New Generation Glaucoma Care MARK MARAMAN, O.D. NOA MEETING KEARNEY, NE OCT 4 TH, 2018 Disclosures I have no financial relationships or conflicts of interest with the manufacturers of any commercial products

More information

Coexisting Cataract with Glaucoma & Role of Phacotrabeculectomy. Dr Mudit Agrawal

Coexisting Cataract with Glaucoma & Role of Phacotrabeculectomy. Dr Mudit Agrawal Coexisting Cataract with Glaucoma & Role of Phacotrabeculectomy Dr Mudit Agrawal Glaucoma and cataract often occur together,especially in elderly and each condition can influence management of the other.

More information

These devices, when FDA approved, are covered for patients with glaucoma that is not adequately controlled with medical therapy.

These devices, when FDA approved, are covered for patients with glaucoma that is not adequately controlled with medical therapy. Medical Policy Title: Aqueous Shunts and ARBenefits Approval: 10/26/2011 Devices for Glaucoma Effective Date: 01/01/2012 Document: ARB0168 Revision Date: Code(s): 66174, Transluminal dilation of aqueous

More information

>$500m. Assessing New Implants. Minimally-Invasive Surgery & Other new devices -a Foretaste

>$500m. Assessing New Implants. Minimally-Invasive Surgery & Other new devices -a Foretaste Minimally-Invasive Surgery & Other new devices -a Foretaste Keith Barton Consultant Ophthalmologist Moorfields Eye Hospital, London Market capitalisation of new glaucoma surgical device companies >$500m

More information

Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery

Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery European Journal of Ophthalmology / Vol. 19 no. 3, 2009 / pp. 393-399 Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery

More information

Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy

Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy File name: Aqueous Shunts and Stents for Glaucoma File code: UM.SURG.18 Origination: New Policy Last Review: 06/2017 Next Review: 06/2018

More information

Endocyclophotodestruction in Glaucoma Patients Undergoing Combined Surgery of Pars Plana Vitrectomy and Phacoemulsification

Endocyclophotodestruction in Glaucoma Patients Undergoing Combined Surgery of Pars Plana Vitrectomy and Phacoemulsification e-issn 643-370 DOI: 0.269/MSM.89097 Received: 204.04.23 Accepted: 204.0.29 Published: 204.0. Endocyclophotodestruction in Glaucoma Patients Undergoing Combined Surgery of Pars Plana Vitrectomy and Phacoemulsification

More information

Treatment ParadigM. Changing the. Faculty: Ike K. Ahmed, MD Eric D. Donnenfeld, MD Malik Y. Kahook, MD

Treatment ParadigM. Changing the. Faculty: Ike K. Ahmed, MD Eric D. Donnenfeld, MD Malik Y. Kahook, MD Supplement to CME Activity September/October 2012 Changing the Glaucoma Treatment ParadigM Faculty: Ike K. Ahmed, MD Eric D. Donnenfeld, MD Malik Y. Kahook, MD L. Jay Katz, MD Richard A. Lewis, MD Thomas

More information

A REVIEW OF MINIMALLY-INVASIVE GLAUCOMA SURGERY (MIGS) Felise May Barte, MD CECOM Symposium 2019

A REVIEW OF MINIMALLY-INVASIVE GLAUCOMA SURGERY (MIGS) Felise May Barte, MD CECOM Symposium 2019 I. Traditional glaucoma surgery A. Trabeculectomy B. Tube Shunt C. Tube versus Trabeculectomy Study Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, Tube Versus Trabeculectomy Study

More information

Developments in Glaucoma Surgery

Developments in Glaucoma Surgery Developments in Glaucoma Surgery Marlene R. Moster, MD Professor of Ophthalmology Thomas Jefferson University School of Medicine Wills Eye Hospital Philadelphia, PA When is surgery indicated? Poor control

More information

4/24/2018. Management of Patients with Conjoint Cataract and Glaucoma. Prevalence of Glaucoma C: NEW WORLD MEDICAL

4/24/2018. Management of Patients with Conjoint Cataract and Glaucoma. Prevalence of Glaucoma C: NEW WORLD MEDICAL Management of Patients with Conjoint Cataract and Glaucoma Bryan Lee, MD, JD 40 th Annual Dallas Spring Ophthalmology Symposium April 27, 2018 Consultant: Allergan, Katena, New World Medical Financial

More information

Learn Connect Succeed. JCAHPO Regional Meetings 2017

Learn Connect Succeed. JCAHPO Regional Meetings 2017 Learn Connect Succeed JCAHPO Regional Meetings 2017 Cataract Surgery in 2017 DARBY D. MILLER, MD MPH CORNEA, CATARACT AND REFRACTIVE SURGERY ASSISTANT PROFESSOR OF OPHTHALMOLOGY MAYO CLINIC FLORIDA Natural

More information

Manchester istent study: 3-year results and cost analysis

Manchester istent study: 3-year results and cost analysis (216) 3, 1365 137 216 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 95-222X/16 www.nature.com/eye Manchester istent study: 3-year results and cost analysis Abstract Purpose

More information

Trabectome. What is a Trabectome? Who is suitable for a Trabectome? By Nathan Kerr and Keith Barton. Eye words to know. MIGS.org

Trabectome. What is a Trabectome? Who is suitable for a Trabectome? By Nathan Kerr and Keith Barton. Eye words to know. MIGS.org MIGS.org Trabectome By Nathan Kerr and Keith Barton What is a Trabectome? The Trabectome is a minimally invasive glaucoma procedure that increases the natural drainage of fluid from the eye by removing

More information

Glaucoma. Glaucoma. Optic Disc Cupping

Glaucoma. Glaucoma. Optic Disc Cupping Glaucoma What is Glaucoma? Bruce James A group of diseases in which damage to the optic nerve occurs as a result of intraocualar pressure being above the physiological norm for that eye Stoke Mandeville

More information

Microinvasive Glaucoma Surgery (MIGS) Nathan Radcliffe, MD New York University New York Eye Surgical Center WAEPS April 1, 2016

Microinvasive Glaucoma Surgery (MIGS) Nathan Radcliffe, MD New York University New York Eye Surgical Center WAEPS April 1, 2016 Microinvasive Glaucoma Surgery (MIGS) Nathan Radcliffe, MD New York University New York Eye Surgical Center WAEPS April 1, 2016 Financial Disclosures Surgical Glaucoma History Glaucoma Surgery Trends 1994-2012

More information

XEN GEL STENT MIGS 4/5/2018 OMAHA AND LINCOLN EYE AND LASER INSTITUTES XEN45 GEL STENT WHY ARE WE LOOKING FOR NEW INNOVATIONS IN GLAUCOMA SURGERY?

XEN GEL STENT MIGS 4/5/2018 OMAHA AND LINCOLN EYE AND LASER INSTITUTES XEN45 GEL STENT WHY ARE WE LOOKING FOR NEW INNOVATIONS IN GLAUCOMA SURGERY? XEN GEL STENT OMAHA AND LINCOLN EYE AND LASER INSTITUTES MARK R. YOUNG, M.D. April 7, 2018 QUESTION: Why are we looking for alternatives to current glaucoma treatment? Look at current surgical glaucoma

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of trabecular stent bypass microsurgery for open-angle glaucoma Primary open-angle

More information

Note: For information about other proposed surgical procedures for treatment of glaucoma see: SURG Viscocanalostomy and Canaloplasty

Note: For information about other proposed surgical procedures for treatment of glaucoma see: SURG Viscocanalostomy and Canaloplasty Subject: Document#: Publish Date: 02/28/2018 Status: Reviewed Last Review Date: 01/25/2018 Description/Scope This document addresses surgical devices used in the treatment of refractory open-angle glaucoma

More information

TRABECULECTOMY THE BEST AND WORST CANDIDATES

TRABECULECTOMY THE BEST AND WORST CANDIDATES TRABECULECTOMY THE BEST AND WORST CANDIDATES MICHAEL F. OATS, MD OPHTHALMIC CONSULTANTS OF BOSTON ASCRS 2014 FINANCIAL DISCLOSURES None TRABECULECTOMY Performed for over 100 years Most commonly performed

More information

GLAUCOMA SURGICAL TREATMENTS

GLAUCOMA SURGICAL TREATMENTS GLAUCOMA SURGICAL TREATMENTS UnitedHealthcare Commercial Medical Policy Policy Number: OPT014 Effective Date: May 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS... 1 COVERAGE

More information

MIGS RESOURCE CENTER

MIGS RESOURCE CENTER Insert to PART 3 OF 3 MIGS RESOURCE CENTER In this episode of the MIGS Resource Center, we talk with Brian Flowers, MD, of Fort Worth, Texas. Dr. Flowers is a renowned glaucoma specialist and has a great

More information

THE TRABECTOME IS A NOVEL SURGICAL DEVICE USED

THE TRABECTOME IS A NOVEL SURGICAL DEVICE USED Delayed-Onset Symptomatic Hyphema After Ab Interno Trabeculotomy Surgery YACHNA AHUJA, MEHRDAD MALIHI, AND ARTHUR J. SIT PURPOSE: To describe patients who have experienced delayed-onset hyphema after ab

More information

4/06/2013. Medication Observation POAG. Proportion. Native American 0.1% 0.4%

4/06/2013. Medication Observation POAG. Proportion. Native American 0.1% 0.4% Clinical Research in Glaucoma: Putting Science into Practice J. James Thimons, O.D., FAAO Chairman, National Glaucoma Society www.nationalglaucomasociety.org Ocular Hypertension Treatment Study (OHTS)

More information

Primary angle closure (PAC) Pathogenesis: Pathogenesis 12/2/2016. Ying Han, MD, PhD Associate Professor of Ophthalmology Glaucoma Service, UCSF

Primary angle closure (PAC) Pathogenesis: Pathogenesis 12/2/2016. Ying Han, MD, PhD Associate Professor of Ophthalmology Glaucoma Service, UCSF Primary angle closure (PAC) Ying Han, MD, PhD Associate Professor of Ophthalmology Glaucoma Service, UCSF Pathogenesis: Pupillary block and anterior lens movement Most common cause Normal pressure gradient

More information

ANSWERS TO YOUR MOST COMMON GLAUCOMA QUESTIONS

ANSWERS TO YOUR MOST COMMON GLAUCOMA QUESTIONS For Your Eyes Only: ANSWERS TO YOUR MOST COMMON GLAUCOMA QUESTIONS www.kremereyecenter.com / 800-694-3937 1 Table of Contents Introduction... 3 Glaucoma Defined... 4 Symptoms of Glaucoma... 6 Treatment

More information

Microinvasive surgical

Microinvasive surgical Improved efficacy expected with second-generation microinvasive glaucoma surgery (MIGS) devices BY ROD MCNEIL Microinvasive surgical approaches to primary openangle glaucoma (POAG) offer minimally traumatic

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Viscocanalostomy and Canaloplasty File Name: Origination: Last CAP Review: Next CAP Review: Last Review: viscocanalostomy_and_canaloplasty 11/2011 6/2017 6/2018 6/2017 Description

More information

1/16/2018. Brett J. Teague, M.D. Big Country Eye Center Abilene, Texas

1/16/2018. Brett J. Teague, M.D. Big Country Eye Center Abilene, Texas Brett J. Teague, M.D. Big Country Eye Center Abilene, Texas I developed the course material/information independently No relevant financial relationship exists by anyone in control of presentation content

More information

Goals. Glaucoma PARA PEARL TO DO. Vision Loss with Glaucoma

Goals. Glaucoma PARA PEARL TO DO. Vision Loss with Glaucoma Glaucoma Janet R. Fett, OD Drs. Kincaid, Fett and Tharp So Sioux City, NE eyewear21@hotmail.com Goals Understand Glaucoma Disease process Understand how your data (objective and subjective) assists in

More information

and done ONE CYPASS MICRO-STENT IS ALL IT TAKES TO DELIVER ON THE PROMISE OF MIGS SAFE, CONSISTENT, LONG-TERM IOP CONTROL

and done ONE CYPASS MICRO-STENT IS ALL IT TAKES TO DELIVER ON THE PROMISE OF MIGS SAFE, CONSISTENT, LONG-TERM IOP CONTROL FOR THE REDUCTION OF IOP IN MILD TO MODERATE PRIMARY OPEN-ANGLE GLAUCOMA AT THE TIME OF CATARACT SURGERY and done ONE CYPASS MICRO-STENT IS ALL IT TAKES TO DELIVER ON THE PROMISE OF MIGS SAFE, CONSISTENT,

More information

GLAUCOMA SURGICAL TREATMENTS

GLAUCOMA SURGICAL TREATMENTS GLAUCOMA SURGICAL TREATMENTS UnitedHealthcare Oxford Clinical Policy Policy Number: VISION 023.20 T2 Effective Date: April 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF COVERAGE...

More information

AB-INTERNO CANALOPLASTY THE MINIMALLY INVASIVE GLAUCOMA SURGERY THAT KEEPS ITS PROMISE

AB-INTERNO CANALOPLASTY THE MINIMALLY INVASIVE GLAUCOMA SURGERY THAT KEEPS ITS PROMISE WHITEPAPER AB-INTERNO CANALOPLASTY THE MINIMALLY INVASIVE GLAUCOMA SURGERY THAT KEEPS ITS PROMISE AB-INTERNO CANALOPLASTY: TREATMENT STEPS 12-MONTH CASE SERIES REVIEW ABiC Canaloplasty performed with an

More information

Cataract Surgery in Patients with Uveitis

Cataract Surgery in Patients with Uveitis Cataract Surgery in Patients with Uveitis Chris Kalogeropoulos MD, PhD, FEBO Professor of Ophthalmology Faculty of Medicine, University of Ioannina President of Hellenic Society for the Study of Ocular

More information

Preliminary ASCRS CyPass Withdrawal Consensus Statement 1

Preliminary ASCRS CyPass Withdrawal Consensus Statement 1 Preliminary ASCRS CyPass Withdrawal Consensus Statement 1 ASCRS CyPass Withdrawal Task Force Leads: Douglas Rhee, MD; Nathan Radcliffe, MD; and Francis Mah, MD Glaucoma: Leon Herndon, MD; Marlene Moster,

More information

November/December Supplement to CRST. Cataract & Refractive Surgery Today MICRO-STENT. Charting the New Course for MIGS.

November/December Supplement to CRST. Cataract & Refractive Surgery Today MICRO-STENT. Charting the New Course for MIGS. Supplement to CRST Cataract & Refractive Surgery Today November/December 2016 CyPass MICRO-STENT Charting the New Course for MIGS Sponsored by CYPASS MICRO-STENT CONTENTS 3 MIGS: A NEW ERA IN GLAUCOMA

More information

Hydrus. What is a Hydrus Microstent? By Nathan Kerr and Keith Barton. Eye words to know. MIGS.org

Hydrus. What is a Hydrus Microstent? By Nathan Kerr and Keith Barton. Eye words to know. MIGS.org MIGS.org Hydrus By Nathan Kerr and Keith Barton What is a Hydrus Microstent? The Hydrus Microstent is a small flexible scaffold inserted into the natural drainage channel of the eye to lower eye pressure

More information

MicroPulse P3. A Burst of Good News for those with Glaucoma

MicroPulse P3. A Burst of Good News for those with Glaucoma MicroPulse P3 Cyclophotocoagulation - A Burst of Good News for those with Glaucoma There is a new type of minimally invasive glaucoma surgery (MIGS) that has quietly joined the fray in the battle against

More information

2/6/2018. Andrew Siedlecki, M.D.

2/6/2018. Andrew Siedlecki, M.D. Andrew Siedlecki, M.D. Siedlecki Cataract and Vision Care Optimization- Improved Uncorrected VA Reduced Spectacle Dependency Minimize Complications Fast Rehabilitation Provide Options for Patients Optometrists

More information

Save time at your check-in and register online before your appointment! It s as easy as 1-2-3

Save time at your check-in and register online before your appointment! It s as easy as 1-2-3 Save time at your check-in and register online before your appointment! It s as easy as 1-2-3 1. Go online to www.blackhillseyes.com 2. Click this logo on our home page for the link to register: 3. Set-up

More information

BrightFocus Foundation is the new name for American Health Assistance Foundation.

BrightFocus Foundation is the new name for American Health Assistance Foundation. In this section, you will find the following: Glaucoma Medications Laser Therapies Conventional Surgical Procedures In the second section, you will find information on how to search for potential treatments

More information

MEDICAL POLICY SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) EFFECTIVE DATE: 03/20/14 REVISED DATE: 03/19/15, 03/17/16, 4/20/17, 04/19/18

MEDICAL POLICY SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) EFFECTIVE DATE: 03/20/14 REVISED DATE: 03/19/15, 03/17/16, 4/20/17, 04/19/18 MEDICAL POLICY SUBJECT: AQUEOUS DRAINAGE DEVICES PAGE: 1 OF: 11 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Treatment ParadigM. Changing the. Faculty: Ike K. Ahmed, MD David F. Chang, MD Eric D. Donnenfeld, MD L. Jay Katz, MD

Treatment ParadigM. Changing the. Faculty: Ike K. Ahmed, MD David F. Chang, MD Eric D. Donnenfeld, MD L. Jay Katz, MD Supplement to CME Activity January 2013 Changing the Glaucoma Treatment ParadigM Faculty: Ike K. Ahmed, MD David F. Chang, MD Eric D. Donnenfeld, MD L. Jay Katz, MD Richard L. Lindstrom, MD Thomas W. Samuelson,

More information

Technicians & Nurses Program

Technicians & Nurses Program ASCRS ASOA Symposium & Congress Technicians & Nurses Program May 6-10, 2016 New Orleans I have none Sunday, May 8, 2016, 10:30-11:30am Amy Jost, BS, COMT, CCRC Cincinnati Eye Institute Identify the tech

More information

Update on Clinical Outcomes After Trabectome TM Surgery For Open-angle Glaucoma

Update on Clinical Outcomes After Trabectome TM Surgery For Open-angle Glaucoma Update on Clinical Outcomes After Trabectome TM Surgery For Open-angle Glaucoma Don Minckler 1, Brian Francis 2, Sameh Mosaed 1, Marina Ramirez 3, Laurie Dustin 2 1 UC Irvine, Irvine CA; Ophthalmology

More information

84 Year Old with Rosacea

84 Year Old with Rosacea 84 Year Old with Rosacea S/p tap and injection of intravitreal vancomycin, ceftazidime, dexamethasone Post-injection day#1 Va HM IOP 14 mmhg Post-injection week#3 BCVA 20/20-3 (plano +0.50 x 180) IOP 23

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary

More information

Correspondence should be addressed to Pedro Arriola-Villalobos; pedro

Correspondence should be addressed to Pedro Arriola-Villalobos; pedro Ophthalmology Volume 206, Article ID 056573, 7 pages http://dx.doi.org/0.55/206/056573 Clinical Study Glaukos istent inject Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients

More information

IRIDEX MicroPulse P3: innovative cyclophotocoagulation

IRIDEX MicroPulse P3: innovative cyclophotocoagulation Romanian Journal of Ophthalmology, Volume 61, Issue 2, April-June 2017. pp:107-111 GENERAL ARTICLE IRIDEX MicroPulse P3: innovative cyclophotocoagulation Gavris M. Monica*, Olteanu Ioana*, Kantor Erzsebet*,

More information

Collaboration in the care of glaucoma patients and glaucoma suspects. Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012

Collaboration in the care of glaucoma patients and glaucoma suspects. Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012 Collaboration in the care of glaucoma patients and glaucoma suspects Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012 Goals of Collaboration Patient-centred and evidence based approach Timely access

More information

CONSENT FOR CATARACT SURGERY REQUEST FOR SURGICAL OPERATION / PROCEDURE AND ANAESTHETIC

CONSENT FOR CATARACT SURGERY REQUEST FOR SURGICAL OPERATION / PROCEDURE AND ANAESTHETIC CONSENT FOR CATARACT SURGERY REQUEST FOR SURGICAL OPERATION / PROCEDURE AND ANAESTHETIC Your doctor has indicated that the condition of your eye appears stable and your cataract surgery and/or implantation

More information

sad EFFECTIVE DATE: POLICY LAST UPDATED:

sad EFFECTIVE DATE: POLICY LAST UPDATED: Medical Coverage Policy Aqueous Shunts and Stents for Glaucoma sad EFFECTIVE DATE: 08 19 2014 POLICY LAST UPDATED: 09 18 2018 OVERVIEW Glaucoma surgery is intended to reduce intraocular pressure (IOP)

More information

WGA. The Global Glaucoma Network

WGA. The Global Glaucoma Network The Global Glaucoma Network Fort Lauderdale April 30, 2005 Indications for Surgery 1. The decision for surgery should consider the risk/benefit ratio. Note: Although a lower IOP is generally considered

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 60 Effective Health Care Program Treatment for Glaucoma: Comparative Effectiveness Executive Summary Background Glaucoma is a leading cause of visual impairment

More information

Managing & Avoiding Post-Op Complications in Tube Surgeries

Managing & Avoiding Post-Op Complications in Tube Surgeries Managing & Avoiding Post-Op Complications in Tube Surgeries K. Sheng Lim St. Thomas Hospital, London shenglim@gmail.com Current GDD Molteno 1969 Baerveldt 1990 Ahmed 1993 Current GDD GDD Plate Material

More information

Review of the Ahmed versus Baerveldt study 5-year treatment outcomes

Review of the Ahmed versus Baerveldt study 5-year treatment outcomes Perspective Page 1 of 5 Review of the Ahmed versus Baerveldt study 5-year treatment outcomes Victor Koh 1,2, Cecilia Maria Aquino 1, Paul Chew 1,2 1 Department of Ophthalmology, National University Hospital,

More information

Glaucoma. How is Glaucoma Diagnosed? Glaucoma Testing

Glaucoma. How is Glaucoma Diagnosed? Glaucoma Testing Glaucoma How is Glaucoma Diagnosed? Glaucoma Testing There is no single test for glaucoma. The diagnosis is made by evaluating the patient from a number of perspectives, using specialized instruments.

More information

Endoscopic Photocoagulation

Endoscopic Photocoagulation Endoscopic Photocoagulation Making a Difference. Empowerm ECP transcends prior technical limitations and offers a bright, new solution for the treatment of glaucoma. Endoscopic CycloPhotocoagulation (ECP)

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of trabeculotomy ab interno for open-angle glaucoma Treating glaucoma by removing

More information